Why the study?
Does pacemaker therapy reduce recurrent syncope in patients with recurrent severe vasovagal syncope?
Does pacemaker therapy reduce recurrent syncope in patients with recurrent severe vasovagal syncope?
Pacemaker therapy should not be recommended for vasovagal syncope; confirms lack of efficacy in this RCT.
In this double-blind randomized trial, pacing therapy did not reduce the risk of recurrent syncope in patients with vasovagal syncope. Because of the weak evidence of efficacy of pacemaker therapy and the risk of complications, pacemaker therapy should not be recommended as first-line therapy for patients with recurrent vasovagal syncope.
No takes yet. Share an insight, caveat, or question.
Connolly et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: